Pacala Mark L 4
4 · Oncology Institute, Inc. · Filed Nov 21, 2022
Insider Transaction Report
Form 4
Pacala Mark L
Director
Transactions
- Award
Common Stock
2022-11-17+2,160→ 52,780 total - Award
Common Stock
2022-11-17+29,057→ 81,837 total
Footnotes (1)
- [F1]Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date.